Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion
- PMID: 14676194
- DOI: 10.1074/jbc.M312372200
Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion
Abstract
Mesothelin is a glycosylphosphatidylinositol-linked cell surface molecule expressed in the mesothelial lining of the body cavities and in many tumor cells. Based on the finding that a soluble form of mesothelin specifically binds to ovarian carcinoma cell line OVCAR-3, we isolated cDNAs encoding a mesothelin-binding protein by expression cloning. The polypeptides encoded by the two cloned cDNA fragments matched to portions of CA125, an ovarian cancer antigen and a giant mucin-like glycoprotein present at the surface of tumor cells. By flow cytometric analysis and immunoprecipitation, we demonstrate that CA125 binds to mesothelin in a specific manner. Binding of CA125 to membrane-bound mesothelin mediates heterotypic cell adhesion as anti-mesothelin antibody blocks binding of OVCAR-3 cells expressing CA125 to an endothelial-like cell line expressing mesothelin. Finally, we show that CA125 and mesothelin are co-expressed in advanced grade ovarian adenocarcinoma. Taken together, our data indicate that mesothelin is a novel CA125-binding protein and that CA125 might contribute to the metastasis of ovarian cancer to the peritoneum by initiating cell attachment to the mesothelial epithelium via binding to mesothelin.
Similar articles
-
Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.Mol Cancer. 2006 Oct 26;5(1):50. doi: 10.1186/1476-4598-5-50. Mol Cancer. 2006. PMID: 17067392 Free PMC article.
-
A binding domain on mesothelin for CA125/MUC16.J Biol Chem. 2009 Feb 6;284(6):3739-49. doi: 10.1074/jbc.M806776200. Epub 2008 Dec 15. J Biol Chem. 2009. PMID: 19075018 Free PMC article.
-
Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery.Cancer Lett. 2007 Mar 8;247(1):130-6. doi: 10.1016/j.canlet.2006.03.029. Epub 2006 May 4. Cancer Lett. 2007. PMID: 16677756 Free PMC article.
-
[Tumor Marker CA125: biochemical and molecular properties].Bull Cancer. 2009 May;96(5):597-601. doi: 10.1684/bdc.2009.0859. Epub 2009 May 12. Bull Cancer. 2009. PMID: 19435686 Review. French.
-
Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment.Expert Rev Anticancer Ther. 2018 Feb;18(2):177-186. doi: 10.1080/14737140.2018.1418326. Epub 2017 Dec 21. Expert Rev Anticancer Ther. 2018. PMID: 29241375 Review.
Cited by
-
Characterization of mesothelin gene expression in dogs and overexpression in canine mesotheliomas.Front Vet Sci. 2024 Sep 9;11:1436621. doi: 10.3389/fvets.2024.1436621. eCollection 2024. Front Vet Sci. 2024. PMID: 39315086 Free PMC article.
-
GlcNAc6ST2/CHST4 Is Essential for the Synthesis of R-10G-Reactive Keratan Sulfate/Sulfated N-Acetyllactosamine Oligosaccharides in Mouse Pleural Mesothelium.Molecules. 2024 Feb 7;29(4):764. doi: 10.3390/molecules29040764. Molecules. 2024. PMID: 38398516 Free PMC article.
-
Exploring the glycosylation of serum CA125.Int J Mol Sci. 2013 Jul 26;14(8):15636-54. doi: 10.3390/ijms140815636. Int J Mol Sci. 2013. PMID: 23896595 Free PMC article.
-
Clinical impacts of mesothelin expression in gastrointestinal carcinomas.World J Gastrointest Pathophysiol. 2016 May 15;7(2):218-22. doi: 10.4291/wjgp.v7.i2.218. World J Gastrointest Pathophysiol. 2016. PMID: 27190694 Free PMC article. Review.
-
Chemotherapeutic Efficacy of Implantable Antineoplastic-Treatment Protocols in an Optimal Mouse Model for Human Ovarian Carcinoma Cell Targeting.Int J Mol Sci. 2018 Oct 4;19(10):3030. doi: 10.3390/ijms19103030. Int J Mol Sci. 2018. PMID: 30287783 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous